About 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide
5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide (PubChem CID 59587463) has the molecular formula C19H20N6O2
and a molecular weight of 364.41 g/mol. Its IUPAC name is 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide.
Analyze 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide?
The IUPAC name of 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide (CID 59587463) is 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide.
What is the SMILES notation for 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide?
The canonical SMILES for 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide is NC(=O)c1nc(Nc2cccnc2)oc1-c1ccc(N2CCNCC2)cc1.
What is the InChIKey of 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide?
The InChIKey is DCQOAMZCSBFOKW-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20N6O2/c20-18(26)16-17(27-19(24-16)23-14-2-1-7-22-12-14)13-3-5-15(6-4-13)25-10-8-21-9-11-25/h1-7,12,21H,8-11H2,(H2,20,26)(H,23,24).
What are the key properties of 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide?
5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide has a molecular weight of 364.41 g/mol, XLogP of 1.99, 5 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(4-piperazin-1-ylphenyl)-2-(pyridin-3-ylamino)-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 59587463), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).